Elekta has announced its plans for the commercial release of Atlantic - a high-field MRI-guided radiation therapy system. The anticipated game-changing technology will be introduced in 2017, with the first systems delivered a year later. In 2012, as part of a wider engagement, DCA Design International worked with Elekta to create a future vision for the industrial design and usability of the Atlantic system.
The extensive project drew on DCA's full service offering. The future vision was informed by a detailed evidence base and grounded with collaborative technical review. A body of evidence was collected from visits to seven treatment sites worldwide, over 90 hours of observations (approximately 360 treatment sessions) and over 50 in-depth interviews with health care professionals, thought-leaders and system stakeholders.
As well as providing a grounded, aspirational vision for the Atlantic system, the broad evidence base and detailed design language has informed the development of a number of other projects within Elekta.
'It was a real pleasure for DCA to work with Elekta's Atlantic project team on such an exciting and game changing development. Throughout the engagement Elekta clearly demonstrated a commitment to evidence based decision making, placing the needs of the patients and health care professionals firmly at the centre of their vision for the future of radiotherapy, affirming their position as a world leader in their field'. Rob Woolston (DCA - Managing Director).
